Emerson, a technology and engineering company, completed the acquisition of Fluxa, a digital collaboration platform. Financial terms were not disclosed. “The life sciences industry has grown rapidly, and speed to market has become increasingly important since the emergence of COVID-19. Emerson’s automation solutions and market leadership, combined with Fluxa’s software, automates technology transfer in one step, giving bio-pharmaceutical companies unprecedented agility to get therapies safely to patients during this critical time,Mark Bulanda, Emerson Automation Solutions Executive President.